Translate Bio, Inc.Company Review & Valuation

TBIO
Nasdaq

About Translate Bio, Inc.

Translate Bio, Inc., a messenger RNA therapeutics company, engages in developing medicines to treat diseases caused by protein or gene dysfunction. It is developing MRT5005 that is in Phase I/II clinical trial for the treatment of cystic fibrosis; and MRT5201 for the treatment of ornithine transcarbShow moreamylase deficiency. It has strategic alliances with Sanofi Pasteur. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. was founded in 2011 and is headquartered in Lexington, Massachusetts.Show less

Industry
Biotechnology
HQ Location
Lexington, Massachusetts

Stock Price

Price data not available for Translate Bio, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Atara Biotherapeutics
United Therapeutics
Vertex Pharmaceuticals
RedHill Biopharma

back to top